DSIP dose range

The amounts people commonly use, from the low end to the high end, with syringe units, schedule and half-life. The 8 published studies are one click away.

Human trials Brain Also called delta sleep-inducing peptide, emideltide, Deltaran

Common use ranges

From user guides and clinic write-ups. No drug label exists, and no study has tested these amounts in people. Vendor and compounding guides agree on before bed dosing and a 100 to 500 mcg range. The compounding source starts lower at 50 mcg. No trial has tested shots under the skin.

Half-life
Not on the site yet, being checked
How it is taken
subcutaneous injection
How long people use it
Ranges from 1 to 3 week runs, or only on bad nights, up to 8 to 12 weeks nightly.
Mixing used for the units
5 mg vial + 2 mL water. 1 unit on a U-100 insulin syringe = 25 mcg.
Total amount per day, by tier
Starting100 mcg / dayTypical200 mcg / dayHigher500 mcg / day
TierEach doseSyringe units5 mg vial + 2 mL waterHow oftenScheduleVial lastsat this tier
Starting [1]100 mcg4 units 0.04 mLonce a day50 to 100 mcg, 30 to 60 minutes before bed6+ weeks
Typical [2]200 mcg8 units 0.08 mLonce a day200 to 300 mcg before bedabout 4 weeks
Higher [3]500 mcg20 units 0.20 mLonce a day400 to 500 mcg before bed10 days

Good to know

  • Taken 30 to 60 minutes before bed.
  • Try one dose for 5 to 7 nights before moving up.
  • Going above 100 mcg has not reliably improved sleep.
  • Some use 100 to 200 mcg earlier in the day for stress.

Sources for these amounts

  1. Starting: FormBlends, DSIP dosage protocols · Matrix Advanced Solutions, DSIP · Bio Hack Lab, DSIP 5 mg guide
  2. Typical: Matrix Advanced Solutions, DSIP · Bio Hack Lab, DSIP 5 mg guide
  3. Higher: Matrix Advanced Solutions, DSIP · Bio Hack Lab, DSIP 5 mg guide

How long people use it: FormBlends, DSIP dosage protocols · Bio Hack Lab, DSIP 5 mg guide

This page shows what labels, clinics and users report, and what studies gave. It is not medical advice and not a recommendation for anyone. Many of these compounds are not approved for human use. Check your own medicines and lab work with a licensed clinician before using anything.

See the science: 8 published studies

Amounts given to people in studies

Lowest25 nmol/kg IV, one time
Most used25 nmol/kg IV, nightly for 3 to 4 nights
Highest100 nmol/kg IV bolus, two doses in one day (surgery patients)

How it was given: IV (slow injection)

25 nmol/kg is about 0.02 mg/kg. Studies are old (1981 to 2009) and small.

Amounts given to animals in studies

Lowest1 mg IV, one time (dog)
Most used1 or 2 mg IV, one time (dog)
Highest2 mg IV, one time (dog)

Read this first. Insomnia trials disagree. Early open studies looked good, later double-blind ones found weak or no clinical benefit. Human doses are in nmol per kg, not mg.

Every study used for this page

Proof grade: Human trials. Tested in randomized human trials. Amounts are quoted as each study reported them. Where the abstract does not state an amount, the row says so.

StudyWho was studiedAmount given, as reportedRouteHow oftenHow longWhat the authors reported
PMID 7028502Schneider-Helmert and Schoenenberger, Experientia 1981Human, 6 middle-aged chronic insomniacs25 nmoles/kgIVOne timeOne nightLonger, less broken sleep. No daytime sleepiness
PMID 3792404Schneider-Helmert, Eur Neurol 1986Human, 18 chronic insomniacs (middle-aged and elderly)6 x 30 nmol/kgIV6 doses over one week1 week, plus 1 week follow-upSleep returned to normal values by end of follow-up
PMID 3622582Schneider-Helmert, Eur Neurol 1987Human, 14 chronic insomniacs, double-blind placebo-controlledNot stated in the abstractInjection (route not in abstract)Nightly7 nightsBetter night sleep and better daytime alertness
PMID 3583493Monti et al, Int J Clin Pharmacol Res 1987Human, insomniacs, double-blind crossover25 nmol/kgIVNightly4 nightsSmall sleep gains, judged of little clinical value
PMID 1299794Bes et al, Neuropsychobiology 1992Human, 16 chronic insomniacs, double-blind parallel groups25 nmol/kgIVAfternoon before each of 3 nights3 daysWeak effects. Not likely of major benefit
PMID 7777652Spath-Schwalbe et al, Psychoneuroendocrinology 1995Human, healthy young men (n=5 per arm, plus 10)3 and 4 mg totalIV infusionOne timeAbout 2 hoursNo effect on ACTH or cortisol
PMID 19142086Pomfrett et al, Eur J Anaesthesiol 2009Human, 24 women having surgery, randomized (12 on DSIP)25, 50 or 100 nmol/kgIV bolusTwo doses (awake, then under anesthesia)One surgeryRaised heart rate and lightened anesthesia depth
PMID 6379493Kato et al, Neuroendocrinology 1984Dog (n=4), plus 1 monkey and 3 rats1 or 2 mgIVOne timeBlood taken every 5 minutesCleared fast. Half-life 4.0 min (dog), 2.9 min (monkey), 2.0 min (rat)

How to read the study numbers

  • One study, one group. Each figure is what one team chose for its own participants or animals.
  • Route matters. An amount given into a vein (IV) is not the same as the same amount under the skin, in the nose or by mouth.
  • Animals are not small people. An animal amount is shown as the study gave it. It is not a human amount.
  • Short studies. Many studies ran days or weeks. They do not show what happens over longer use.

Common questions

What amounts of DSIP were used in human studies?

In the studies listed here, people were given from 25 nmol/kg IV, one time up to 100 nmol/kg IV bolus, two doses in one day (surgery patients). The amount used most often was 25 nmol/kg IV, nightly for 3 to 4 nights. These are what study teams chose for their participants under supervision.

Where do these DSIP numbers come from?

From 8 published studies, each linked to its PubMed or ClinicalTrials.gov record. Every figure was checked against the study abstract or its open full text. Proof grade: Human trials.

Is this a recommendation for how much DSIP to use?

No. This page shows the amounts reported by drug labels, clinics and users, next to what researchers gave in studies. It is not medical advice and not a recommendation for anyone. Talk to a licensed clinician before using any of it.

See all peptides